Medicare Enrolled
Dr. Chris McGee, MD
Family Medicine · Decatur, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McGee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McGee
Dr. Chris McGee is a family medicine specialist in Decatur, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. McGee performed 8,927 Medicare services across 3,880 unique beneficiaries.
Between the years covered by Open Payments, Dr. McGee received a total of $6,733 from 50 pharmaceutical and/or device companies across 404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McGee is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in TX
$6,733 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,927
Medicare services
Top 2% in TX for family medicine
3,880
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~446 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,164 | $90 | $257 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,579 | $0 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,304 | $60 | $174 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
455 | $61 | $162 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
337 | $0 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
333 | $10 | $59 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
204 | $16 | $43 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
172 | $2 | $9 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
147 | $124 | $271 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
140 | $34 | $114 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 116 | $206 | $472 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
105 | $16 | $44 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
101 | $10 | $40 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
64 | $59 | $206 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
60 | $25 | $74 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
60 | $25 | $141 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
57 | $62 | $205 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
53 | $28 | $71 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
52 | $0 | $18 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
51 | $207 | $555 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
50 | $36 | $115 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
47 | $33 | $57 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $73 | $257 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
30 | $1 | $20 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
28 | $50 | $128 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
17 | $35 | $122 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
17 | $81 | $214 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
16 | $43 | $130 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
16 | $12 | $119 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $100 | $329 |
| Knee X-ray, 4 or more views An imaging test using X-rays to create multiple pictures of the knee joint from different angles. |
15 | $36 | $96 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
15 | $158 | $395 |
| Extended office visit by clinical staff, first hour An extended office or outpatient visit provided by clinical staff lasting at least one hour. |
14 | $13 | $28 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
13 | $42 | $176 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
13 | $24 | $75 |
| Ankle X-ray, minimum 3 views An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints. |
12 | $26 | $80 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
12 | $102 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,733
Total received (2018-2024)
Avg $962/year across 7 years
Top 9% in TX for family medicine
50
Companies
404
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,456 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$278 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$652
2023
$1,204
2022
$1,031
2021
$1,085
2020
$873
2019
$915
2018
$974
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,175
ABBVIE INC.
$553
Boehringer Ingelheim Pharmaceuticals, Inc.
$416
Novo Nordisk Inc
$340
Astellas Pharma US Inc
$336
AbbVie Inc.
$295
PFIZER INC.
$292
Allergan, Inc.
$254
MIMEDX Group, Inc.
$210
Lilly USA, LLC
$210
Takeda Pharmaceuticals U.S.A., Inc.
$200
GlaxoSmithKline, LLC.
$187
GM Pharmaceuticals, Inc.
$165
Radius Health, Inc.
$163
Allergan Inc.
$162
Amarin Pharma Inc.
$160
Daiichi Sankyo Inc.
$143
Abbott Laboratories
$122
Corcept Therapeutics
$119
Novartis Pharmaceuticals Corporation
$97
SHIELD THERAPEUTICS INC
$96
SANOFI-AVENTIS U.S. LLC
$90
Biohaven Pharmaceuticals, Inc.
$87
Corium, LLC
$86
Exact Sciences Corporation
$77
Smith+Nephew, Inc.
$66
Supernus Pharmaceuticals, Inc.
$59
Janssen Pharmaceuticals, Inc
$58
Shire North American Group Inc
$48
Tris Pharma Inc
$43
Merck Sharp & Dohme Corporation
$36
Smith & Nephew, Inc.
$33
Genentech USA, Inc.
$33
Amgen Inc.
$31
Teva Pharmaceuticals USA, Inc.
$30
Antares Pharma, Inc.
$23
Sunovion Pharmaceuticals Inc.
$23
Orexigen Therapeutics, Inc.
$23
Curonix LLC
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Promius Pharma LLC
$18
Gilead Sciences, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$17
Horizon Therapeutics plc
$15
Inspire Medical Systems, Inc.
$15
kaleo, Inc.
$15
Dexcom, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
Paratek Pharmaceuticals, Inc.
$13
Top 3 companies account for 31.8% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIMOVIG · AIRSUPRA · AJOVY · ASSURITY · AUVI-Q · AZSTARYS · Aimovig · Austedo XR · Azstarys · BELSOMRA · BREZTRI · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · DALVANCE · Descovy · Dexcom G6 Transmitter · Dyanavel XR · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · INJECTAFER · INSPIRE · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Myrbetriq · NURTEC ODT · NUZYRA · OFEV · Ozempic · PICO 7 · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PREVNAR - 13 · PROCLAIM · Proclaim IPG · QELBREE · QULIPTA · QUVIVIQ · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · STIOLTO RESPIMAT · SYMBICORT · Santyl · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Trintellix · Tymlos · UBRELVY · VESICARE · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vanacof · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in TX.
Equivalent to $75 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
92
Per 100K population
127.1
County median income
$89,897
Nearest hospital
MEDICAL CITY DECATUR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McGee is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), with low-engagement industry engagement in the top 9% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McGee experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McGee performed 3,164 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McGee receive payments from pharmaceutical companies?
Yes. Dr. McGee received a total of $6,733 from 50 companies across 404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGee's costs compare to other family medicine physicians in Decatur?
Dr. McGee's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Decatur
Browse family medicine physicians in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology